Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol CC100A CC100: Safety and Tolerability of Single Doses

NCT02050334 is registered in ClinicalTrials.gov with Chemigen, LLC as lead sponsor.

NCT NCT02050334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02050334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol CC100A CC100: Safety and Tolerability of Single Doses
Lead sponsor
Chemigen, LLC
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2013
Completion date
February 28, 2015
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy